Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Japan Hospice Holdings Inc. (7061.T)
Tokyo, JP
Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.00% | -10.23% | -11.77% | -32.90% | -50.70% | -39.75% | -43.23% | -79.88% | -67.18% | -62.23% | -62.23% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+17.0% ★ Q1'26: +18.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-56.8% Q1'26: +44.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+2.3% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+6.0% Q1'26: +6.9% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+3.4% Q1'26: +4.3% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.7% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×9.20× Q1'26: 7.68× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.19B
est: 4.25B (-1.3%)
|
4.92B
est: 4.90B (+0.3%)
|
6.02B
est: 6.11B (-1.5%)
|
7.89B
est: 8.00B (-1.3%)
|
9.87B
est: 10.00B (-1.3%)
|
12.12B
est: 12.60B (-3.8%)
|
14.17B
est: 16.20B (-12.5%)
|
20.00B
20.00B – 20.00B
+23.5% YoY
|
17.30B
17.30B – 17.30B
-13.5% YoY
|
18.60B
18.60B – 18.60B
+7.5% YoY
|
| EBITDA |
627.55M
est: 645.36M (-2.8%)
|
532.54M
est: 743.97M (-28.4%)
|
852.01M
est: 927.69M (-8.2%)
|
1.40B
est: 1.21B (+15.6%)
|
1.79B
est: 1.52B (+17.9%)
|
1.82B
est: 1.90B (-4.1%)
|
1.43B
est: 2.44B (-41.2%)
|
3.01B
3.01B – 3.01B
+23.5% YoY
|
2.60B
2.60B – 2.60B
-13.5% YoY
|
2.80B
2.80B – 2.80B
+7.5% YoY
|
| EBIT |
498.17M
est: 474.74M (+4.9%)
|
363.03M
est: 547.28M (-33.7%)
|
623.39M
est: 682.43M (-8.7%)
|
1.07B
est: 893.52M (+19.4%)
|
1.38B
est: 1.12B (+23.5%)
|
1.29B
est: 1.37B (-6.2%)
|
849.00M
est: 1.76B (-51.9%)
|
2.18B
2.18B – 2.18B
+23.5% YoY
|
1.88B
1.88B – 1.88B
-13.5% YoY
|
2.03B
2.03B – 2.03B
+7.5% YoY
|
| Net Income |
297.89M
est: 350.87M (-15.1%)
|
107.06M
est: 105.76M (+1.2%)
|
240.80M
est: 242.17M (-0.6%)
|
454.73M
est: 470.91M (-3.4%)
|
681.88M
est: 741.19M (-8.0%)
|
639.58M
est: 842.77M (-24.1%)
|
278.01M
est: 1.23B (-77.5%)
|
1.69B
1.69B – 1.69B
+36.6% YoY
|
350.80M
350.80M – 350.80M
-79.2% YoY
|
401.52M
401.52M – 401.52M
+14.5% YoY
|
| SGA |
340.76M
est: 206.49M (+65.0%)
|
331.72M
est: 238.04M (+39.4%)
|
342.95M
est: 296.82M (+15.5%)
|
383.12M
est: 388.64M (-1.4%)
|
344.00M
est: 485.80M (-29.2%)
|
425.00M
est: 535.62M (-20.7%)
|
525.88M
est: 688.66M (-23.6%)
|
850.19M
850.19M – 850.19M
+23.5% YoY
|
735.42M
735.42M – 735.42M
-13.5% YoY
|
790.68M
790.68M – 790.68M
+7.5% YoY
|
| EPS |
40.30
est: 41.80 (-3.6%)
|
13.62
est: 12.60 (+8.1%)
|
30.29
est: 28.85 (+5.0%)
|
56.73
est: 56.10 (+1.1%)
|
84.82
est: 88.30 (-3.9%)
|
77.88
est: 99.70 (-21.9%)
|
33.08
est: 146.00 (-77.3%)
|
199.50
199.50 – 199.50
+36.6% YoY
|
41.50
41.50 – 41.50
-79.2% YoY
|
47.50
47.50 – 47.50
+14.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-01 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shinichiro Kato | Executive Vice President, Chief Financial Officer & Director | — | male |
| Tadashi Takahashi | President, Chief Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7061.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
